In HFD-fed mice treated with antibiotics, however, accumulated T-β-MCA inhibits intestinal FXR signaling and subsequently suppresses intestinal ceramide synthesis, leading to improvements in hepatic steatosis and hepatic injury (85). Here, NR1H4 is linked to fatty liver disease.